Cancer Communications (Aug 2022)

DNA methylation signature predicts cancer response to demethylation agents from profiling diverse cancer cell lines

Zhifu Sun,
Xuewei Wang,
Pete Vedell,
Jean‐Pierre Kocher

Affiliations

Zhifu Sun: Division of Computational Biology Department of Quantitative Health Sciences Mayo Clinic Rochester MN 55905 USA
Xuewei Wang: Division of Computational Biology Department of Quantitative Health Sciences Mayo Clinic Rochester MN 55905 USA
Pete Vedell: Division of Computational Biology Department of Quantitative Health Sciences Mayo Clinic Rochester MN 55905 USA
Jean‐Pierre Kocher: Division of Computational Biology Department of Quantitative Health Sciences Mayo Clinic Rochester MN 55905 USA

DOI: https://doi.org/10.1002/cac2.12326
Journal volume & issue: Vol. 42, no. 8
pp. 789 – 792

Abstract

No abstracts available.

Published in Cancer Communications

ISSN: 2523-3548 (Online)
Publisher: Wiley
Country of publisher: Australia
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://onlinelibrary.wiley.com/journal/25233548

About the journal